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Abstract
Background and Objectives: It is questionable whether existing outcome measurement instruments (OMIs) in dementia 
research reflect what key stakeholders’ value. We attained consensus from more than 300 key stakeholders, including 
people living with dementia, and identified 13 core outcome items for use in nonpharmacological and community-based 
interventions for people with dementia living at home. In this systematic review, we review OMIs that have previously been 
used in dementia care research to determine how, or even if, the 13 core outcome items can be measured.
Research Design and Methods: We extracted self-reported OMIs from trials, reviews, and reports of instrument development. 
Searches were undertaken in the ALOIS database, MEDLINE, PsycINFO, CINAHL, SocINDEX, and COSMIN databases. 
We aimed to assess the psychometric properties of OMI items for face validity with the core outcome items, content validity, 
internal consistency, and responsiveness. We held a coresearch workshop involving people living with dementia and care 
partners in order to ratify the findings.
Results: In total 347 OMIs were located from 354 sources. Of these, 76 OMIs met the inclusion criteria. No OMIs were 
deemed to have sufficient face validity for the core outcome set (COS) items, and no OMIs proceeded to further assessment. 
The “best” available OMI is the Engagement and Independence in Dementia Questionnaire.
Discussion and Implications: This study provides a practical resource for those designing dementia research trials. Being 
able to measure the COS items would herald a paradigm shift for dementia research, be responsive to what key stakeholders 
value and enhance the ability to make comparisons.
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Background and Objectives
There has been a recent proliferation of outcomes and 
outcome rating tools in the field of dementia research 
(Couch, Lawrence, Co, & Prina, 2020; Harrison, Noel-
Storr, Demeyere, Reynish, & Quinn, 2016; Rockwood 
& Gauthier, 2006). However, the value of this degree 
of activity might be called into question. The idea of re-
search waste may be uncomfortable for many research 
stakeholders (Chalmers & Glasziou, 2009; Glasziou & 
Chalmers, 2019; Nasser et al., 2017) and, in the context of 
outcomes and outcome measures, there are two key issues. 
The first is one of relevance, or whether outcome constructs 
and the content of measurement instruments reflect what 
key stakeholders value. In other words, who defines how 
effectiveness is measured? Two reviews of outcome meas-
urement instruments have found that cognitive outcomes 
dominate dementia studies (Couch et al., 2020; Harrison 
et  al., 2016). Given there are questions over the impor-
tance of cognitive outcomes to key research stakeholders 
(Reilly et al., 2020) relative to other outcomes, it has been 
suggested that cognitive measurement instruments are often 
chosen because there is an expectation to do so (Couch 
et al., 2020). Couch and colleagues (2020) note that this 
is in contrast to the inclusion of cognitive outcomes being 
based on a sound and logical theory on how interventions 
will create change.
A recent systematic review of outcomes of importance 
to people with prodromal or early stages of dementia, 
their care partners, and health care professionals found 
that studies evaluating new interventions rarely include 
outcomes of importance to nonprofessional stakeholders 
(Tochel et  al., 2019). If outcomes and measurement 
instruments have insufficient relevance to nonprofes-
sional research beneficiaries, particularly those with lived 
experience, it raises the question of whether or not re-
search can claim to create high-quality evidence that will 
improve the lives of people living with dementia. Included 
in this is the need to ensure measures reflect the language 
and priorities of those affected by dementia (Morbey 
et al., 2019).
The second issue concerns the sheer volume and het-
erogeneity of outcomes and measurement instruments. 
This has been noted by many in the field of dementia 
studies (Dawson, Bowes, Kelly, Velzke, & Ward, 2015; 
Reilly et al., 2015; Sansoni et al., 2007) and is evident in 
recent National Institute for Health and Care Excellence 
guidelines (2018). A recent scoping review of measurement 
instruments used in randomized controlled trials (n = 91) 
of nonpharmacological interventions for mild cogni-
tive impairment and mild dementia found a high degree 
of variation in the use of measurement instruments. The 
researchers found that just more than 20% of measurement 
instruments were used in more than one of the trials in-
cluded in the review. The researchers conclude that “further 
research is needed to understand which outcomes should 
be prioritized and how they should be measured” (Couch 
et al., 2020, p. 13).
A lack of consistency impedes meta-analysis, cross-study 
comparisons for effectiveness, and creates a lack of clarity 
when trying to interpret research findings (Williamson, 
Altman, Blazeby, Clarke, Devane, et al., 2012). Here, the 
outcome “quality of life” is a good example as there are 
as many as 45 quality of life instruments available for 
application in dementia research (Martyr et  al., 2018). 
Furthermore, as pointed out by Bowling and colleagues 
(2015), many of the key outcome tools for use in dementia 
research lack a theoretical basis and fail to accommodate 
the views of key nonprofessional stakeholders, particularly 
people living with dementia.
Issues of relevance and heterogeneity in outcomes for 
dementia research could be offset by consensus exercises 
that aim to attain agreement on both the outcomes 
and the measurement instruments of those outcomes. 
However, there are notable inconsistencies in the six con-
sensus exercises that have already been conducted in the 
field of nonpharmacological and psychosocial research 
for dementia (EU Joint Programme—Neurodegenerative 
Disease Research, 2015; International Consortium for 
Health Outcomes Measurement, 2016; Katona et  al., 
2007; Moniz-Cook et  al., 2008; ROADMAP Project, 
2018; Webster et  al., 2017; Table  1). It is important to 
note that two of the six consensus exercises did not con-
sult those with lived experience of dementia. In all con-
sensus exercises, poor reporting means it is not clear 
whether the participation of people living with de-
mentia was meaningfully facilitated (Reilly et al., 2020). 
Cognition featured in four of six consensus exercises, 
with three measurement instruments recommended 
(Montreal Cognitive Assessment, Mini-Mental State 
Examination, and Alzheimer’s Disease Assessment 
Scale—Cognitive subscale). Quality of life featured in 
all six consensus exercises, resulting in the recommen-
dation of six measurement instruments (Quality of life 
in Alzheimer’s Disease [QOL-AD], Dementia Quality 
of Life Instrument, QUALIDEM, Dementia Quality 
of Life Measure [DEMQOL], Quality of Life in Late-
Stage Dementia, and Quality of Wellbeing Scale—Self 
Administered). Activities and/or instrumental activities of 
daily living featured in three consensus exercises, with five 
measurements recommended for use (Lawton Physical 
Self Maintenance–Instrumental Activities of Daily Living, 
The Katz Index of Independence in Activities of Daily 
Living, Alzheimer’s Disease Cooperative Study—Activities 
of Daily Living, Bristol Activity Daily Living Scale, and 
Disability Assessment for Dementia). The only area of 
consistent agreement is for neuropsychiatric and behav-
ioral outcomes, which featured in five consensus exercises, 
and four recommended the Neuropsychiatric Inventory 
as the measurement instrument of choice (two consensus 
exercises do not recommend measures).
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Table 1. Summary of Outcome Consensus Recommendations
Author, year of pub-
lication Scope specification Stakeholders involved Consensus process
Outcomes recommended 
(including categories or 
domains, outcome and 
outcome measures con-
cerning people living with 
dementia—if reported
Katona et al., 2007 Care: Defining and 
measuring treat-
ment benefit in 
dementia
34 professionals and 2 carers Two consensus group 
meetings
Cognition; behavioral and 
psychological symptoms; 
quality of life; global 
assessments; activities of 
daily living




search in dementia 
care
Up to 19 experts participated 
in the face-to-face con-
sensus workshops. 131 
professionals and 5 carers 
involved in web-based con-
sultation.
Three face-to-face con-
sensus workshops  
A web-based pan-
European consulta-
tion (E-mail)  
A systematic literature 
review
Mood (CSDD or GDS-
12); Patient Quality of 
Life (QOL-AD, DQOL, 
EQ-5D); Patient ADL/
IADL (Lawton PSMS-
IADL); Patient behavior 
(NPI); Global patient 
measures (GBS, CIBIC-
Plus)







search in dementia 
care (update of 
Moniz-Cook et al., 
2008)
Number of participants who 
participated in Workshop 
1 is not reported. However, 
Workshop 2 involved 25 
professionals. Attendees for 
Workshop 3 also unclear 
but assumed to be 25.  
Consultation with people 
living with dementia was 
piloted with five people. 
It is reported that after 
the pilot the consultation 
involved 25 people living 
with dementia and 18 
carers.
Three face-to-face con-
sensus workshops  
Consultation with 
people living with de-
mentia and carers  
Desk-based work
Mood (CSDD, GDS-15, 




quality of life (EQ-5D); 
ADL/IADL (Lawton 
PSMS-IADL, Katz ADL, 
ADCS-ADL, BADSL, 
DAD)
ICHOM, 2016 Care: All types and 
all stages of de-
mentia
19 professionals, 3 people 
living with dementia and 
1 carer
Literature review  
Discussions with 
persons with de-
mentia and patient 
represented groups  
Workshop (participant 
groups unclear)
Symptoms, Functioning & 
Quality of Life: Neu-
ropsychiatric (NPI); 
Cognitive (MOCA); social 
(includes community 
affairs and relationships, 
but no outcome measure 
recommended); daily living 
(BADSL); overall quality 
of life and well-being 
(QOL-AD & QWB-SA)  
Sustainability: Time to full-
time care  
Safety: Falls  
Clinical status: Disease 
progression (CDR); hos-
pital admissions; overall 
survival 
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There is significant scope to improve the meaningful-
ness and consistent use of outcome measures for evalua-
tion studies of interventions for dementia (Couch et  al., 
2020; Tochel et  al., 2019). Importantly, the emergence 
of core outcome sets (COS) has begun to address the is-
sues of relevance and heterogeneity in outcome measures 
that may ultimately improve the quality of the evidence 
base (Glasziou & Chalmers, 2019; Williamson, Altman, 
Blazeby, Clarke, Devane, et al., 2012; Williamson, Altman, 
Blazeby, Clarke, & Gargon, 2012; Williamson et al., 2017). 
COS developers use rigorous and robust methods to attain 
consensus from key professional and lay stakeholders as to 
what outcomes should be measured as a minimum across 
all evaluation studies. Recommendations can then be made 
on how to quantify and measure the outcomes, through 
a systematic review of the measurement properties of 
instruments which leads to recommendations of which 
instruments are the best match for the COS. The use of 
COS ensures that researchers measure what is relevant to 
all stakeholders, enabling comparisons across studies and 
minimizing research waste (Williamson, Altman, Blazeby, 
Clarke, Devane, et al., 2012; Williamson, Altman, Blazeby, 
Clarke, & Gargon, 2012).
The development and promotion of uptake of COS 
have been spearheaded by the Core Outcome Measures for 
Effectiveness Trials initiative (http://www.comet-initiative.
org/). To the best of our knowledge, there is only one other 
COS that has been developed in the field of dementia; it 
focuses on physical activity interventions (Gonçalves, 
Samuel, Ramsay, Demain, & Marques, 2019). We identified 
13 core outcome items for use in nonpharmacological and 
community-based health and social care interventions for 
people with dementia living at home (Harding et al., 2018, 
2019; Morbey et al., 2019; Reilly et al., 2020). Below, we 
provide a summary of each study phase.
Phase 1
In the first phase, we used qualitative methods to consult 
with key stakeholders (people living with dementia [n = 17], 
Author, year of pub-
lication Scope specification Stakeholders involved Consensus process
Outcomes recommended 
(including categories or 
domains, outcome and 
outcome measures con-
cerning people living with 
dementia—if reported
Webster et al., 2017 Care: Disease 
modification 
interventions for 
people living with 
mild to moderate 
dementia
4 people living with de-
mentia, 13 carers, and 1 PPI 
member were involved in 
the patient and public in-
volvement consultation and 
E-mail consultation.  
29 professionals participated 
in the consensus conference.
Systematic review  
Patient and public in-
volvement consulta-
tion (focus groups, 
follow-up E-mail 
consultation, and an 
unspecified number 
of interviews)  
Consensus conference
Core: Cognition (MMSE OR 
ADAS-Cog); biological 
markers (MRI)  
Important, but not core: 
Neuropsychiatric 
symptoms (NPI); ADL 
(DAD); quality of life 
(DEMQOL); global 
functioning (CDR)
ROADMAP, 2018 Care: To identify a 




from preclinical to 
severe stages
29 people living with de-
mentia in patient and 
public involvement consul-
tation.  
25 people living with de-
mentia, 70 carers, and 238 
professionals participated 
in surveys.
Systematic review  




holder surveys (for 
people living with 
dementia, carers, and 
professionals)
Functional ability and inde-
pendence; patient quality 
of life; behavioral and neu-
ropsychiatric symptoms; 
cognitive abilities
Notes: Adapted from Reilly et al., 2020. We have summarized these according to the three domains present in the Core Outcome Set—Standards for Devel-
opment (COS-STAD) recommendations: scope specification, stakeholders involved, and consensus process (Kirkham et al., 2017). ADAS-COG = Alzheimer’s 
Disease Assessment Scale—Cognitive subscale; ADL = Activities of Dailing Living; ADCS-ADL = Alzheimer’s Disease Cooperative Study—Activities of 
Daily Living; BADSL = Bristol Activity Daily Living Scale; CDR = Clinical Dementia Rating; CIBIC-Plus = Clinician Interview-Based Impression of Change 
plus caregiver input; CSDD  =  Cornell Scale for Depression in Dementia; DAD  =  Disability Assessment for Dementia; DEMQOL  =  Dementia Quality 
of Life Questionnaire; DQOL = Dementia Quality of Life Instrument; EQ-5D = EuroQol Five Dimension; GBS = Gottfries–Brane–Steen Rating Scale; 
GDS = Geriatric Depression Scale; MMSE = Mini-Mental State Examination; MOCA = Montreal Cognitive Assessment; MRI = Magnetic Resonance Im-
aging; NPI = Neuropsychiatric Inventory; PPI = Patient and Public Involvement; PSMS-IADL = Physical Self Maintenance—Instrumental Activities of Daily 
Living; QUALIDEM = Dementia Quality of Life Instrument; QOL-AD = Quality of life in Alzheimer’s Disease; QUALID = Quality of Life in Late-Stage 
Dementia; QWB-SA = Quality of Well-being Scale—Self Administered; RAID = Rating Anxiety in Dementia.
Table 1. Continued
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care partners [n = 18], health and social care professionals 
[n = 15], policymakers [n = 4], and researchers [n = 1]) about 
what outcomes are important in nonpharmacological and 
community-based health and social care interventions for 
people with dementia living at home (Harding et al., 2019). 
We supplemented outcomes from the qualitative data with 
outcomes identified from a literature review of trials, quali-
tative research, and key policy documents. We produced an 
initial long list of 170 outcomes and through research team 
workshops we reduced the long list to 54 outcomes items 
(Harding et al., 2019).
Phase 2
In Phase 2, we used a modified two-round Delphi survey 
(Round 1, n = 288; Round 2, n = 246; 85% response rate 
between rounds) and a consensus meeting to attain con-
sensus on which of the 54 outcomes are regarded as core. 
The research team worked alongside 25 coresearchers—
people with a diagnosis of dementia (n  =  18) and care 
partners (n  =  7)—to design an accessible Delphi survey 
(Morbey et al., 2019). Thirteen outcomes were identified as 
core (Reilly et al., 2020; Figure 1).
In this article, we present the third phase of the 
study—a systematic review of self-reported measurement 




The protocol for this review is registered with PROSPERO 
(Reilly et al., 2019). The Consensus-based Standards for the 
selection for health Measurement Instruments (COSMIN) 
group is a recognized authority on how to assess meas-
urement instruments for inclusion in a COS. COSMIN 
places particular importance on two areas: content va-
lidity (including face validity) and internal consistency 
(Prinsen et al., 2016). We focused on these two areas and 
also assessed responsiveness—that is, the degree to which a 
measurement instrument is sensitive to change—due to its 
importance to trialists and COS developers (Prinsen et al., 
2016).
We drew on COSMIN guidance, although we used face 
validity as an initial screening process. Face validity and 
content validity, though similar concepts, have important 
differences and in this review, we operationalized these 
concepts to align with the aims and objectives of the re-
view. In the psychometric literature, face validity and 
content validity are assessments of the content of measure-
ment instruments against the stated aim of the instrument, 
that is, the construct(s) or outcome(s) that the instrument 
is purported to measure. Face validity is concerned with 
whether an instrument appears to be an adequate reflection 
to the concept of interest, particularly from the perspectives 
of potential respondents. Content validity is concerned with 
whether instruments are representative of the constructs of 
interest (Bowling, 2005; Colton & Covert, 2007). The con-
struct of interest in this study was the predefined 13 COS 
items rather than the stated aim of the instrument.
Given the overlap, evaluations of face validity and con-
tent validity are often undertaken together. We conducted 
an initial screening phase before assessing content validity, 
internal consistency, and responsiveness. The screening 
phase was concerned with ascertaining face validity, that 
is, basic relevance and whether an instrument and the 
items within were adequate reflections of the COS items. In 
COSMIN guidance face validity is part of content validity. 
Our screening phase enabled us to separate face validity 
assessments from broader content validity assessments. 
Our review was driven by two questions:
 1. What is the face validity of outcome measurement 
instruments in relation to our established COS of items?
 2. What is the methodological quality as determined by 
content validity, internal consistency, and responsive-
ness of outcome measurement instruments with ade-
quate face validity?
Literature Searches
Searching for peer-reviewed studies and trials to extract 
primary and secondary measures
The Cochrane Dementia and Cognitive Improvement 
Group, at the Medical Sciences Division at Oxford 
Figure 1. Final Core Outcome Set (COS): thirteen core outcome items 
categorized under the domains used within the Delphi.
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University, manages the ALOIS database, which is a com-
prehensive and open-access database of dementia studies 
(http://www.medicine.ox.ac.uk/alois/). ALOIS is updated 
by monthly searches of MEDLINE, Embase, PsycINFO, 
Web of Science Core Collection, ClinicalTrials.gov, 
World Health Organisation International Clinical Trial 
Registry Platform meta-registry, Cochrane Controlled 
Register of Controlled Trials, and LILACs (via Bireme). 
The database contains records of randomized controlled 
trials, controlled clinical trials, and other “open-label” 
studies. The ALOIS database was used to extract meas-
urement instruments used in existing studies evaluating 
nonpharmacological interventions from inception in 2008 
to July 2019.
Searching for peer-reviewed reviews and reports of 
measurement instrument development
The following databases were searched for reviews (of 
interventions, outcomes, and measurement instruments) 
and publications that report on or describe the develop-





 • COSMIN database of reviews
For the COSMIN database, all relevant reviews 
categorized under the 10th revision of the International 
Statistical Classification of Diseases and Related Health 
Problems were searched. For the other databases, searches 
extracted records for a period covering the last 10 years 
from January 2009 to December 2019. Three search 
strings were designed. Two search strings focused on de-
mentia and terms designed to focus on outcome measure-
ment instruments. Added to these were strings tailored 
to each of the 13 outcome items and the initial concep-
tual domains used to categorize the outcome items in the 
Delphi survey. The two search strings are outlined below. 
These were followed by search strings designed to focus on 
each outcome item and conceptual domain (for string 3 see 
Supplementary Appendix 1):
 S1 AB (dementia OR alzheimer*) OR TI (dementia OR 
alzheimer*)
 S2 (AB outcome* (measure* OR assessment* OR scale 
OR instrument*) OR TI outcome* (measure* OR as-
sessment* OR scale OR instrument*) AND (S1)
Inclusion and exclusion criteria
Sources were screened by title and abstract followed by 
full-text screening (by A.  J. E.  Harding, H.  Morbey, and 
S. Reilly). The following inclusion criteria were applied to 
all trials, reviews (including studies and or measurement 
instruments listed within reviews), and reports of measure-
ment instrument development:
Types of participants
 • People with dementia living at home in their 
neighborhood/community.
Types of interventions
 • Any U.K.-based or international nonpharmacological 
intervention focusing on people living with dementia at 
home, which aimed to support people living with de-
mentia in their neighborhoods and communities. This 
included for example assistive technology (e.g., trials 
investigating the efficacy/outcomes associated with 
cognitive aids, environmental sensors, video and audio 
technologies, and advanced integrated sensor systems 
used in the home for people with dementia); psychoso-
cial (e.g., psychodynamic approaches, reminiscence and 
life review therapy, support groups, reality orientation, 
memory training, and cognitive/behavioral approaches); 
psychological; social; nutritional (excluding medical 
supplements); educational; literature-based (e.g., book 
clubs); carer-focused interventions if outcomes for 
people living with dementia were reported.
Types of measurement instrument
 • Reported to have been completed by a person living 
with dementia (i.e., a self-reported instrument) or an in-
strument with a self-report version.
 • A subjective measure (including visual measures).
 • English language is used.
The following exclusion criteria were applied:
Types of participants
 • People without dementia
 • People living with dementia in a clinical health care set-
ting (e.g., hospital) or any form of residential care (e.g., 




 • Other medical device-driven interventions.
Type of measurement instrument
 • Solely or partly designed to be completed by proxy (e.g., 
a professional or care partner)
 • Solely or partly based on observation of the person
 • Administered as an objective assessment, test, or exam 
designed for diagnostic or screening purposes
 • Diary methods
 • Measures personalized based on participant consultation
 • Not in English
 • A resource use economic measure.
Locating measurement instruments
All measurement instruments found and logged in the 
searches were located by using the original publication 
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or, given its emerging use in systematic reviews (Bramer, 
Rethlefsen, Kleijnen, & Franco, 2017; Gehanno, Rollin, & 
Darmoni, 2013), a targeted search on Google or Google 
Scholar.
Assessments
We assessed for face validity using the most recent COSMIN 
scale (1, Inadequate; 2, Doubtful; 3, Adequate; 4, Very 
Good). This required assessing each instrument item for 
relevance against each core outcome item. Two reviewers 
independently rated the items in each instrument (A. J. E. 
Harding, H. Morbey, S. Reilly, F. Ahmed, C. Opdebeeck, 
I.  Leroi, R.  Elvish, and J.  Keady). Items were considered 
good enough if they were rated adequate or very good. 
Reviewers’ ratings were compared by both to locate 
inconsistencies in scoring between inadequate/doubtful and 
adequate/very good. Inconsistencies were resolved through 
discussion between the two reviewers or decided on by the 
third reviewer. Based on COSMIN guidance, 85% of items 
in measurement instruments needed to have adequate face 
validity in order to proceed to further psychometric assess-
ment (Terwee et al., 2018). Methods for assessing content 
validity, internal consistency, and responsiveness can be 
found in the latest guidance published by the COSMIN 
group (Mokkink et al., 2018).
Coresearcher involvement
In the final part of the review, we sought feedback from 
a coresearch group. The purpose of the workshop was 
to discuss the relevance and suitability of measurement 
instruments found to be the most appropriate for the COS 
through the systematic review. The group was facilitated 
by researchers (A. J. E. Harding, H. Morbey, and S. Reilly) 
and was comprised of people living with dementia and 
care partners. Participants had either been involved in 
earlier study phases or were recruited from local groups 
or memory cafes, and some were already familiar with the 
aims, objectives, and methods of the study.
Results
Outcome measurement instruments were extracted from 
354 sources (146 reviews, 205 trials, and 3 reports of meas-
urement instrument development; Figure  2). We located 
347 measurement instruments, of which 78 met the in-
clusion criteria for further assessment. However, one in-
strument had the same items on a different scale and was 
not assessed (EQ-5D-3L) and one instrument could not 
be located (Geriatric Coping Schedule). Subsequently, 76 
measurement instruments were assessed.
Face Validity Assessments
The 76 instruments had a total of 1,373 items. The av-
erage number of items per tool was 20. A total of 17,849 
assessments was made with consistency in rating among 
reviewers in 96% (17,305) of assessments. Further discus-
sion or the input of a third reviewer was needed in 4% 
(n  =  544) of assessments. The measurement instruments 
and percentage of items deemed to have relevance (and 
how many COS items this relates to) are presented in 
Table 2. No instruments met the face validity threshold of 
85% of items having at least adequate face validity with 
single or multiple COS items. Most instruments had ex-
tremely low relevance in respect of face validity with COS 
items, with some having no relevance whatsoever. On this 
basis, no instruments were assessed for broader content va-
lidity, internal consistency, and responsiveness. However, 
four instruments stood out as being more relevant when 
compared to the wider field. Our criteria for relevance 
is the number/percentage of COS items covered in the 
instrument.
The fourth most relevant instrument is the Older 
Americans’ Resources and Services Instrumental Activities 
of Daily Living (OARS-IADL), where 10 of 14 items (71%) 
mapped on to 5 (38%) of COS items: “meaningful activ-
ities,” “alertness,” “knowing where you are,” “personal 
hygiene and cleanliness,” and “vision and hearing.” The 
OARS-IADL instrument did not have adequate focus on 
“losing interest,” “falls,” “maintaining a sense of who you 
are,” “having a laugh,” “communication,” “importance 
of relationships,” “feeling safe and secure,” and “feeling 
valued and respected by others.”
The Adult Social Care Outcome Toolkit (ASCOT) tool 
was the third most relevant instrument to measure COS 
items. The ASCOT tool had adequate or very good face 
validity for 5 of 8 ASCOT items (63%), which covered 
6 of 13 COS items (46%): “meaningful activities,” “per-




















on Records idenfied through database 
searching 
n =  21,437
Trials idenfied through ALOIS
n =   205
Records aer duplicates removed
n =   6,032
Records excluded
n =  5,672
Full-text arcles excluded, with 
reasons
n = 6
(Protocol n = 1, study n = 3, Opinion piece 
n =2)
Records tle/abstract 
screened n = 6,032
Full-text arcles assessed 
for eligibility
n = 360
Sources included in OMI 
extracon
n = 354
(Reviews n = 146 Trials n = 205, 
OMI development n = 3)
Figure 2. PRISMA flowchart for literature search.
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No. of items in 
the instrument 
relevant to COS 
items
% of items 
in OMI rele-
vant to COS 
items
Engagement and Independence in Dementia Ques-
tionnaire
26 7 53.85 19 73.08
Nottingham Health Profile 45 7 53.85 8 17.78
Adult Social Care Outcome Toolkit 8 6 46.15 5 62.50
Older Americans’ Resources and Services Instru-
mental Activities of Daily Living
14 5 38.46 10 71.43
World Health Organisation Quality of Life 100 100 5 38.46 6 6.00
Lille Apathy Rating Scale 31 4 30.77 15 48.39
Bath Assessment of Subjective Quality of Life in De-
mentia
17 4 30.77 5 29.41
Health Status Questionnaire-12 12 4 30.77 3 25.00
Ryff Psychological Wellbeing Scale 42 4 30.77 6 14.29
Sickness Impact Profile 136 4 30.77 10 7.35
World Health Organisation-5 5 3 23.08 2 40.00
The Quality of Life Scale 16 3 23.08 4 25.00
Older People’s Quality of Life Brief Version 14 3 23.08 3 21.43
Long Term Conditions Questionnaire 20 3 23.08 4 20.00
Older People’s Quality of Life 36 3 23.08 3 8.33
Apathy Evaluation Scale—S 18 2 15.38 8 44.44
The ICEpop CAPability measure for Older people 5 2 15.38 2 40.00
Short Form Health Survey-12 9 2 15.38 3 33.33
Personal Wellbeing Index 7 2 15.38 2 28.57
15D 15 2 15.38 3 20.00
Dementia Quality of Life 5 2 15.38 1 20.00
Geriatric Depression Scale Short 15 2 15.38 2 13.33
Frontal Systems Behavior Scale 46 2 15.38 5 10.87
Control, Autonomy, Self-Realisation and Pleasure 
Scale-19
19 2 15.38 2 10.53
Self Management Ability Scale 30 2 15.38 3 10.00
DEMQoL 29 2 15.38 2 6.90
Geriatric Depression Scale-30 29 2 15.38 1 3.45
Apathy Inventory—Patient 3 1 7.69 1 33.33
Lubben Social Network Scale 12 1 7.69 3 25.00
Starkstein Apathy Scale 14 1 7.69 3 21.43
Lawton Physical Self-Maintenance Scale 14 1 7.69 3 21.43
The Dementia Quality of Life Instrument 5 1 7.69 1 20.00
Dementia Quality of Life Instrument—Revised 6 1 7.69 1 16.67
EQ-5D 6 1 7.69 1 16.67
Relationship Satisfaction Scale 7 1 7.69 1 14.29
Short Form Health Survey-36 36 1 7.69 5 13.89
The Cornell–Brown Scale for Quality of Life in De-
mentia
8 1 7.69 1 12.50
Duke Health Profile 17 1 7.69 2 11.76
General Self Efficacy Scale 10 1 7.69 1 10.00
Neuropsychiatric Inventory 12 1 7.69 1 8.33
Quality of Life in Alzheimer’s Disease 12 1 7.69 1 8.33
The Herth Hope Index 12 1 7.69 1 8.33
Philadelphia Geriatric Centre Morale Scale 17 1 7.69 1 5.88
Cornell Scale for Depression in Dementia 19 1 7.69 1 5.26
Self-Esteem Scale 23 1 7.69 1 4.35
General Health Questionnaire-28 28 1 7.69 1 3.57
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relationships,” “feeling safe & secure,” and “feeling valued 
and respected by others.” The ASCOT tool did not have an 
adequate focus on “losing interest,” “alertness,” “knowing 
where you are,” “vision & hearing,” “a sense of who you 
are,” “having a laugh,” and “communication.”
The second most relevant instrument was the 
Nottingham Health Profile (NHP). However, while this 
instrument was relevant for 7 (54%) of 13 COS items, 
only 8 of 45 items (18%) in the instrument were rele-
vant. The NHP covers “meaningful activities,” “losing 
interest,” “personal hygiene and cleanliness,” “falls,” 
“communication,” “importance of relationships,” and 
“feeling valued and respected by others.” It does not 
cover “knowing where you are,” “alertness,” “vision and 
hearing,” “a sense of who you are,” “having a laugh,” and 
“feeling safe and secure.”
The most relevant instrument to measure the COS 
was the Engagement and Independence in Dementia 
Questionnaire (EID-Q; Stoner, Orrell, & Spector, 2018). 
The EID-Q instrument had adequate or very good face 
validity for 7 of 13 COS items (54%). Overall, 19 of the 
26 items in the EID-Q had very good or adequate face va-
lidity (73%). The COS items that the EID-Q covers are 
“meaningful activities,” “losing interest,” “personal hy-
giene and cleanliness,” “a sense of who you are,” “com-
munication,” “importance of relationships,” and “feeling 
valued and respected by others.” There is an inadequate 
focus on “alertness,” “knowing where you are,” “vision & 
hearing,” “falls,” “having a laugh,” and “feeling safe & se-
cure” (Table 3).
Collectively, the EID-Q and ASCOT covered 9 of 13 COS 












No. of items in 
the instrument 
relevant to COS 
items
% of items 
in OMI rele-
vant to COS 
items
The Life Satisfaction Scale 31 1 7.69 1 3.23
Dyadic Adjustment Scale 31 1 7.69 1 3.23
State-Trait Anxiety inventory 40 1 7.69 1 2.50
Autobiographical Memory Interview 21 0 0.00 0 0.00
Beck Anxiety Inventory 21 0 0.00 0 0.00
Behavioural Pathology in Alzheimer’s Disease 25 0 0.00 0 0.00
Brief Assessment of Prospective Memory—Short 
Form
16 0 0.00 0 0.00
Cohen Mansfield Agitation Inventory 29 0 0.00 0 0.00
COOP/WONCA Charts 6 0 0.00 0 0.00
Duke AD 7 0 0.00 0 0.00
Geriatric Anxiety Inventory 20 0 0.00 0 0.00
General Health Questionnaire-12 12 0 0.00 0 0.00
Iconographical Falls Efficacy Scale 10 0 0.00 0 0.00
Index for Managing Memory Loss 44 0 0.00 0 0.00
Interpersonal Reactivity Index 28 0 0.00 0 0.00
International Physical Activity Questionnaire 23 0 0.00 0 0.00
Lawton Instrumental Activities of Daily Living 8 0 0.00 0 0.00
Nottingham Extended Activities of Daily Living scale 22 0 0.00 0 0.00
Penn State Worry Questionnaire 16 0 0.00 0 0.00
Perceived Stress Scale 10 0 0.00 0 0.00
Physical Activity Scale For The Elderly 12 0 0.00 0 0.00
Physical Self-Maintenance Scale 6 0 0.00 0 0.00
Pittsburgh Sleep Quality Index 11 0 0.00 0 0.00
Positive Psychology Outcome Measure 16 0 0.00 0 0.00
Rosenberg Self-Esteem Scale 10 0 0.00 0 0.00
Short Form Health Survey-8 8 0 0.00 0 0.00
Short Falls Efficacy Scale [85] 7 0 0.00 0 0.00
The Brief Resilience Scale 6 0 0.00 0 0.00
The Spirituality Index of Well-Being 12 0 0.00 0 0.00
Yale Physical Activity Survey 36 0 0.00 0 0.00
Note: OMI = outcome measurement instrument; COS = core outcome set; AD, Alzheimer’s disease; COOP/WONCA = Dartmouth Primary Care Cooperative 
Research Network/World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians; DEMQoL - De-
mentia Quality of Life Questionnaire; EQ-5D = EuroQol Five Dimension.
Table 2. Continued
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“alertness,” “knowing where you are,” “vision & hearing,” 
and “having a laugh.” The administration of the EID-Q and 
ASCOT would involve research participants completing 34 
items, with 24 items (71%) having at least adequate face va-
lidity. A configuration of ASCOT and OARS-IADL also cov-
ered 9 of 13 COS items. Neither focused on losing interest, 
a sense of who you are, having a laugh, and communication. 
The administration of both tools would involve research 
participants completing 22 items, with 15 items (68%) having 
at least adequate face validity. A configuration of the EID-Q, 
ASCOT, and OARS-IADL covers all items, except for the item 
“having a laugh.” These three instruments have 48 items, of 
which 34 (71%) have at least adequate face validity. However, 
we cannot simply recommend the inclusion of all these 
instruments as the resulting configuration is unlikely to be rep-
resentative of the equal weighting of COS items.
Coresearch Workshop
Nine coresearchers attended the workshop that was split 
into two sessions. Attendees included five people living 
with dementia and four people who had current or prior 
experiences of being a care partner. Three of the people 
living with dementia and two of the care partners had also 
been involved in previous phases of the study as research 
participants and coresearchers. Attendees were split into 
two groups facilitated by researchers (A. J.  E. Harding 
and H. Morbey). In the first session, the two most relevant 
instruments were discussed (EID-Q and ASCOT). We chose 
not to include the NHP in the discussion because, despite 
covering seven COS items, only 18% of the NHP items 
were relevant (as assessed against the 13 COS items). There 
was broad agreement that many of the items in the EID-Q 
and ASCOT were relevant for the identified COS items.
In the second session, a configuration of instruments 
capable of capturing 12 of the COS items (i.e., all items 
except the item “having a laugh”) was presented to the 
coresearchers. This configuration was EID-Q, ASCOT, and 
OARS-IADL (total of 48 items). Participants were asked 
how they would find completing these as a minimum, 
how long it would take, and whether people would face 
any issues when completing them. The coresearch group 
Table 3. The Four Most Relevant Measurement Instruments for Measuring the 13 COS Items
Outcome measurement  
instrument (OMI)
No. of items in 
OMI
Items in the COS that are covered  
in the OMI items: description of COS  
items; number of OMI items (% of COS items)
No. (% of total items in the 
OMI) of OMI items relevant 
to COS items 
Engagement and Independence 
in Dementia Questionnaire
26 Meaningful activities  
Losing interest  
Personal hygiene and cleanliness  
A sense of who you are  
Communication  
Importance of relationships  
Feeling valued and respected by others  
Total: 7 (53.85%)
19 (73.08)
Nottingham Health Profile 45 Meaningful activities  
Losing interest  
Personal hygiene and cleanliness  
Falls  
Communication  
Importance of relationships  
Feeling valued and respected by others  
Total: 7 (53.85%)
8 (17.78)
Adult Social Care Outcome 
Toolkit
8 Meaningful activities  
Personal hygiene and cleanliness  
Falls  
Importance of relationships  
Feeling safe & secure  
Feeling valued and respected by others  
Total: 6 (46.15%) 
5 (62.50)
Older Americans’ Resources 
and Services Instrumental 
Activities of Daily Living
14 Meaningful activities  
Alertness  
Knowing where you are  
Personal hygiene and cleanliness  
Vision and hearing  
Total: 5 (38.46%) 
10 (71.43)
Note: COS = core outcome set; OMI = outcome measurement instrument.
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concluded that the configuration of different instruments, 
all formatted differently and with different scales, was too 
burdensome and overwhelming to consider completing as 
a minimum. The workshop was featured on BBC North 
West Tonight in Summer 2019 showing the discussion be-
tween the coresearchers and researchers and drawings by 
the cartoonist Tony Husband. The news feature is avail-




This systematic review, which sought to find adequate 
instruments to measure 13 identified COS items relating 
to nonpharmacological dementia research, has found that 
no instrument is sufficiently reflective enough of what key 
stakeholders value. First, it is important to discuss how the 
findings inform or develop our thinking around what the 
COS items collectively measure. We previously outlined 
how the COS items may have significantly overlapped with 
the concept of social health (Reilly et al., 2020). Our study 
here found that the scope and focus of the most relevant 
measurement instruments did indeed overlap with so-
cial health, where independence and engagement are key 
constructs. Social independence and engagement are the 
constructs measured by the EID-Q. The OARS-IADL and 
NHP also have some relevance in this review. This is re-
flective of how the concept of social health overlaps with 
some aspects of instrumental activities of daily living, in-
dependence, and health (Dröes et al., 2017). However, the 
central aim of this review was to identify and, if possible, 
recommend measurement instruments in order to measure 
the COS items.
Implications
A key finding of our review of tools is that measurement 
instruments do not sufficiently reflect the COS items. 
Because no measurement instruments met the 85% face 
validity threshold, we did not proceed further with the 
psychometric assessments of the instruments. It is con-
cerning that existing instruments do not adequately re-
flect the areas that key stakeholders value, including 
people living with dementia. Researchers should consider 
whether the existing evidence base provides meaningful 
and good quality evidence. Alternatively, there may be an 
element of research waste (Chalmers & Glasziou, 2009; 
Glasziou & Chalmers, 2019; Nasser et al., 2017). Even if 
the answer to this question rests somewhere in the middle 
of these two perspectives, there is still significant scope 
to improve the evidence base in nonpharmacological de-
mentia research.
It is of interest and concerning that some of the most 
frequently used and endorsed measurement instruments 
have exceptionally low face validity with the COS items. 
For example, 2 of 29 (7%) DEMQOL items were deemed 
to have adequate or very good face validity for 2 COS items 
(15%), and 1 of 12 (8%) QOL-AD items was considered to 
have adequate or very good face validity for 1 COS item.
We have reached a period where there is considerable 
scrutiny regarding who decides what should be measured 
in intervention trials and evaluations. Professionals and 
researchers up until recently have had a dominant role 
(Couch et al., 2020; Reilly et al., 2020; Tochel et al., 2019). 
We also involved those from professional groups in deciding 
which outcome items were considered core. Once they 
were made aware of the perspectives of people living with 
dementia many professionals realigned their own views 
with those of people living with dementia (Reilly et  al., 
2020). The method of consensus, and how consensus was 
attained, is arguably more robust in respect of privileging 
the views of people living with dementia than many ex-
isting approaches where the participation of people living 
with dementia appears to often be limited to the confines of 
a predefined construct of interest.
The EID-Q was found to have the most overlap with 
the scope and focus of the COS items. The EID-Q is a rela-
tively new instrument developed by Stoner and colleagues 
(2018). The researchers consulted 17 people living with 
dementia during the design of the instrument in order to 
elicit perspectives on engagement and independence. Just 
under three quarters of EID-Q items have face validity and 
relevance with 7 of 13 COS items. While we did not un-
dertake a further psychometric assessment as part of this 
review, the instrument has undergone psychometric testing 
with excellent results (Stoner et al., 2018). However, cru-
cially for use in trials, the EID-Q has not at the time of 
writing been assessed for responsiveness or its sensitivity to 
detecting change over time.
While we acknowledge that the EID-Q is currently the 
“best” measurement instrument available, ultimately it 
does not meet our a priori 85% threshold and although it 
has shown promise in psychometric assessments, its sensi-
tivity to change over time has not yet been assessed.
We rated the ASCOT tool as having 5 items that had very 
good or adequate face validity; these covered 6 of 13 COS 
items. The ASCOT tool is widely used in the adult social 
care field, though the instrument was not developed with 
people living with dementia. The inclusion of the ASCOT 
tool in this review is based on the use of an easy-read ver-
sion in a study with people with mild cognitive impairment 
and a self-diagnosis of dementia in Australia (Phillipson, 
Smith, Caiels, Towers, & Jenkins, 2019). However, at the 
time of writing, the ASCOT tool has not yet been fully de-
veloped and tested for administration with people living 
with dementia.
Of the 14 items in the OARS-IADL, 10 (71%) are rel-
evant for 5 COS items. This instrument originates from a 
study on aging and human development published by Duke 
University in the late 1970s. The inclusion of the OARS-
IADL in this review is based on it being part of the Dementia 
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Outcomes Measurement Suite review (Sansoni et al., 2007), 
where it is described as being a significant predictor of 
nursing home admission and service utilization. We found 
no record of the OARS-IADL being used in trials from our 
search of ALOIS records, and given its partial relevance, we 
cannot recommend the use of the OARS-IADL. We did not 
consider recommending the NHP, despite it being on par 
with the EID-Q in terms of relevance for the COS. Our de-
cision is based on less than a fifth of items in the tool being 
regarded as relevant and reflects the views expressed by the 
coresearchers and wider literature. Coresearcher feedback 
from people living with dementia and care partners on the 
prospect of completing the configurations of instruments as 
a minimum was considered too burdensome. This is con-
sistent with existing literature that highlights engaging with 
too many sensitive questions about day-to-day experiences 
places cognitive demands on people living with early-stage 
dementia that is often difficult to manage (Abendstern 
et al., 2019). Although the findings clearly highlight tools 
that are more reflective of the COS than others, we cannot 
comfortably endorse any configuration of existing meas-
ures or individual tools as a COS measure. This conclu-
sion is strengthened by the finding that no tool meets the 
COSMIN guidance that 85% of instrument items should 
have face validity.
Given only one of the four higher scoring tools discussed 
here can currently be considered specific to dementia (EID-
Q), it is worth reflecting on just how dementia specific the 
13 COS items are and whether they may actually have 
wider relevance. This study demonstrates the importance 
of all of the 13 outcome items to people living with de-
mentia, though arguably only the 3 items could be viewed 
as specific to dementia (“losing interest,” “alertness,” and 
“knowing where you are”). It is possible that the COS 
items may well have a broader appeal to the aging research 
agenda; however, further research would be needed. Given 
the rationale for COS is relevant in many fields, aging 
researchers need to fundamentally question and assess the 
quality and relevance of measurement instruments in the 
context of what older people value.
Strengths and Limitations
COS studies require updating periodically, including further 
testing and/or refining with people from different social and 
cultural groups (Reilly et al., 2020). A COS recommends a 
minimum set of measures to enhance comparisons for ef-
fectiveness. It is likely that researchers will use additional 
outcomes and measures that may not focus on the 13 COS 
items but do focus on the intervention’s theory of change 
(Couch et al., 2020). It is important to note that the COS 
and this review does not focus on carer or care partner 
outcomes. Nor does the COS or this review focus on eco-
nomic outcomes.
We focused on subjective measures designed to be 
completed by people living with dementia. We did not 
include in our assessments four measures where the items 
are personalized when completed by the person living with 
dementia because there were no items to assess (1) Quality 
of Life Assessment Schedule, (2) Schedule for Evaluation 
of Individual Quality of Life, (3) Bangor Goal-setting 
Interview, and (4) Canadian Occupational Performance 
Measure. However, two of these measures do have higher-
level domains (Quality of Life Assessment Schedule and 
Canadian Occupational Performance Measure). We were 
not able to examine whether findings from studies that have 
used these measures led to the creation of items that align 
with the 13 COS items. One of the underlying principles for 
COS is that they increase comparisons of effectiveness by 
providing recommendations on what should be measured 
as a minimum in all trials. Ultimately it is unclear how or if 
personalized measures could improve comparisons for ef-
fectiveness given that participants choose the items being 
measured, potentially resulting in a high degree of variation.
It is important to note that how we have defined face 
validity differs from the established definition in the litera-
ture. In the psychometric literature, face validity and con-
tent validity are assessments of the content of measurement 
instruments against the stated aim of the instrument, that 
is, the construct(s) or outcome(s) that the instrument is 
purported to measure. The aim of this review was to as-
sess the relevance of measurement instruments against the 
13 core outcome items, or predefined criteria that are not 
the stated aim of the instrument. Subsequently, the face va-
lidity screening sought to map the COS against the items 
in measurement instruments in order to find measurement 
instruments with significant overlap with the 13 COS items.
The rationale for our definition of face validity and 
for using it as an initial screening process is that first, 
face validity is considered an important driver and guide 
for the selection of measurement instruments among 
COS developers and trialists, including COS developers 
assessing face validity themselves (Prinsen et  al., 2016). 
Second, an important point from the wider literature is 
that face validity assessments are considered good practice 
when assessing the fundamental relevance of instruments in 
the context of being inclusive of respondents’ perspectives 
(Colton & Covert, 2007). In prior phases of our study, the 
research team worked alongside coresearchers, many of 
whom had a diagnosis of dementia, in order to interpret 
the scope and focus of outcomes. We assessed the rele-
vance of measurement instruments against coresearchers’ 
interpretations of outcome items in order to remain 
faithful to the principle of coresearcher involvement in 
shaping these outcome items. Furthermore, 11 of the 13 
COS items originate from qualitative data collection in 
Phase 1 of the study (Reilly et al., 2020) and are therefore 
potentially drawing on different ontological and episte-
mological perspectives when compared to existing and 
established outcome constructs. With this in mind, deter-
mining the basic relevance of measurement instruments 
and items within the scope and focus of the 13 COS items, 
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which privilege the perspectives of people living with de-
mentia, is an important first step.
This study provides a practical resource for those de-
signing research trials of nonpharmacological community-
based interventions for people living with dementia at 
home. We have previously identified 13 core outcome items 
that overlap with social health and that should be meas-
ured as a minimum in all evaluation studies concerning 
nonpharmacological and community-based health and 
social interventions for people with dementia living at 
home. While the COS will require updating periodically, 
it may also require testing and refining with other social 
and cultural groups to ensure wider relevance. This system-
atic review of the measurement instruments that are used 
in nonpharmacological and community-based dementia 
research has found that no tools are relevant enough to 
measure the core outcome items. On this basis, the key 
finding is the extent to which existing instruments have a 
partial focus on what key stakeholders value. Being able to 
measure the COS items would herald a paradigm shift for 
dementia research, be responsive to what key stakeholders 
value, enhance the ability to make comparisons, and reduce 
research waste.
Supplementary Material
Supplementary data are available at The Gerontologist online.
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